These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4131812)

  • 1. [Influencing of the immunosuppressive treatment (trenimon) upon the human-gammaglobulin-skintest in patients with chronic progressive polyarthritis (author's transl)].
    Dölitzscher G; Siering H
    Folia Clin Int (Barc); 1974 Jan; 24(1):64-72. PubMed ID: 4131812
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of long term treatment with trenimon in chronic progressive polyarthritis].
    Kunze M; Paliege R; Tanner E
    Z Gesamte Inn Med; 1975 Oct; 30(20):676-9. PubMed ID: 1216948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the treatment of chronic polyarthritis with cytostatic agents. I. Combined therapy with trenimon and proresid. Clinical and serological studies].
    Chlud K; Prohaska E; Pfaller C
    Z Rheumaforsch; 1967 Jun; 26(5):250-60. PubMed ID: 4878333
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunosuppressive treatment of progressive chronic polyarthritis].
    Seidel R; Reissmann K; Land H; Rödel J
    Z Gesamte Inn Med; 1975 Aug; 30(16):535-8. PubMed ID: 1189506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral massive dose therapy with Trenimon in progressive chronic polyarthritis (PCP)].
    Prohaska E; Chlud K
    Wien Z Inn Med; 1968; 49(1):26-31. PubMed ID: 5737645
    [No Abstract]   [Full Text] [Related]  

  • 6. [Delayed cutaneous immune reactivity in rheumatoid polyarthritis. Its changes during immunosuppressive therapy].
    Lermusiaux JL; Kuntz D; Ryckewaert A
    Rev Fr Etud Clin Biol; 1969 Oct; 14(8):782-7. PubMed ID: 4189484
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problems of immunosuppressive therapy as shown on the example of chronic progressive polyarthritis].
    Jesserer H
    Z Gesamte Inn Med; 1973 Mar; 28(5):68-70. PubMed ID: 4705899
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cellular immune reaction against aggregated human gamma globulin in chronic polyarthritis].
    Rothenberger W; Thiele HG
    Verh Dtsch Ges Rheumatol; 1974; 3(0):46-7. PubMed ID: 4134650
    [No Abstract]   [Full Text] [Related]  

  • 9. [The P phenomenon in progressive chronic polyarthritis (pcP) and collagen diseases].
    Chlud K
    Wien Med Wochenschr; 1969 Apr; 119(17):325-7. PubMed ID: 4389131
    [No Abstract]   [Full Text] [Related]  

  • 10. [Collagen-like protein as an activity criterion in the disease course observation of progressive chronic polyarthritis].
    Hoffmann-Blume E; Kunze M; Sittner S
    Z Gesamte Inn Med; 1973 May; 28(10):285-90. PubMed ID: 4126273
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of therapy on iron metabolism in patients with progressive chronic polyarthritis].
    Siering H; Eitner K
    Z Gesamte Inn Med; 1970 Sep; 25(18):827-30. PubMed ID: 5522138
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of primary chronic polyarthritis with a cytostatic agent of the ethyleneimine group].
    Cruz A
    Z Rheumaforsch; 1970; 29(3):120-4. PubMed ID: 5528257
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunohistochemical detection of antigammaglobulin factors in the serum (author's transl)].
    Geiler G; Schulze A
    Acta Histochem Suppl; 1980; 22():309-11. PubMed ID: 6166963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the treatment of chronic polyarthritis with cytostatic drugs. II. Oral application of Trenimon. Clinical and serological studies].
    Prohaska E; Chlud K; Pfaller C
    Z Rheumaforsch; 1968 Feb; 27(1):39-47. PubMed ID: 5715915
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppressive therapy in rheumatoid arthritis].
    Weigl E; Lehmann G; Krieg D
    Z Gesamte Inn Med; 1971 Sep; 26(17):561-3. PubMed ID: 5125160
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of various parameters of cellular and humoral immunity during the treatment of rheumatoid polyarthritis with D-penicillamine].
    Crouzet J; Guillien P; Boullenger C; Camus JP; Lièvre JA
    Rev Rhum Mal Osteoartic; 1972 Oct; 39(10):601-7. PubMed ID: 5083696
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combined immunosuppressive-antiphlogistic therapy of chronic rheumatic diseases].
    Tanner E; Siering H; Keil K
    Arzneimittelforschung; 1970 Nov; 20(11):1804-6. PubMed ID: 5536997
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experience with local immunosuppressive therapy in rheumatoid arthritis].
    Julkunen H
    Z Rheumaforsch; 1969; 28(1):5-7. PubMed ID: 5810413
    [No Abstract]   [Full Text] [Related]  

  • 19. [On skin reactions to intracutaneous injection of native and aggregated human-gamma-globulin in patients with primary chronic polyarthritis].
    Beickert A; Garten CD
    Z Rheumaforsch; 1966 Feb; 25(1):18-27. PubMed ID: 5997702
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy with chlorambucil in progressive chronic polyarthritis].
    Thumb N; Horak W
    Wien Z Inn Med; 1968; 49(12):462-70. PubMed ID: 4187786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.